The largest database of trusted experimental protocols

Bio plex 200

Manufactured by DiaSorin
Sourced in United States, Canada

The Bio-Plex 200 is a multiplex immunoassay system that utilizes magnetic bead-based technology to detect and quantify multiple analytes simultaneously from a small sample volume. The system employs Luminex xMAP technology to perform rapid, accurate, and reproducible analysis of proteins, cytokines, and other biomolecules.

Automatically generated - may contain errors

20 protocols using bio plex 200

1

Multiplex Immunoassay for Salivary Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Salivary levels of inflammatory biomarkers were determined using multiplex immunoassay kits purchased from R&D Systems (Minneapolis, MN) with a Bio-Plex 200 (Luminex) instrument. Assays were conducted following manufacturer instructions. The mean fluorescence intra-assay coefficient of variation (CV) was 2.99%, inter-assay CV was 10.27%, and the average percent of observed to expected values of known concentration was 99.7%. All values are given in pg/mL.
+ Open protocol
+ Expand
2

Multiplexed Serum Cytokine Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples were stored at -80°C prior to analysis. Samples were tested by the Cytokine Reference Laboratory (University of Minnesota) using the magnetic bead set PRCYTOMAG-40K (EMD Millipore). Samples were analyzed for Non-Human Primate (NHP)-specific TNFα, IFNγ, IL-6 & IL-2 using the Luminex platform and performed as a multi-plex. Fluorescent color-coded beads coated with a specific capture antibody were added to each sample. After incubation and washing, biotinylated detection antibody was added followed by phycoerythrin-conjugated streptavidin. The beads were read on a Luminex instrument (Bioplex 200). Samples were run in duplicate and values were interpolated from five-parameter fitted standard curves.
+ Open protocol
+ Expand
3

Plasma Cytokine Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood samples were collected in pre-chilled EDTA tubes. After collection, the samples were centrifuged at 4°C, plasma was harvested into multiple aliquots, and then stored in a −70°C freezer until the completion of the study.
Plasma TNF-α and IL-6 concentrations (assay ranges 0.8–3100 pg/mL and 0.2–3800 pg/mL, respectively) were determined using a Bio-Plex 200 (Luminex) Instrument, and a high sensitivity bead-based multiplex immunoassay (Performance High Sensitivity Human Cytokine, R& D Systems, Minneapolis, MN), as previously described (Moieni et al., 2015a (link); Moieni et al., 2015b (link)). All plasma samples from each subject (baseline and all subsequent time points) were assayed on the same 96-well plate; every subject demonstrated the expected profile of change of cytokine concentrations over time, based on previous studies (Eisenberger et al., 2010 (link); Eisenberger et al., 2009 (link)). The mean intra-assay CV% of the standards was < 8% for TNF-α and IL-6; the inter-assay CV% of an internal laboratory quality control sample was < 13% for both analytes.
+ Open protocol
+ Expand
4

Luminex Multiplex Immunoassay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The instrument used was a Bio-Plex 200 instrument (Luminex corp., Ebersberg, Germany) and data collection was performed using the Luminex xPONENT 3.1 software. The software has pre-defined detection gates for each microsphere set based on the fluorescence of two impregnated fluorescent dyes. The fluorescence emitted from bound SAPE was also detected and for each microsphere set, a median fluorescence intensity (MFI) was calculated within the software based on a minimum of 500 detectable microspheres. At least two negative controls were included for each batch of samples analyzed on the instrument, and the mean MFI of the negative controls was subtracted from the MFI obtained for each sample. Throughout the initial assay development stages, the background fluorescence did not exceed an MFI of 150, therefore, this was chosen as the minimum threshold for which a sample was considered positive.
+ Open protocol
+ Expand
5

Multiplex Cytokine Profiling in NHP

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples were stored at -80°C prior to analysis. Samples were tested by the Cytokine Reference Laboratory (University of Minnesota) using the magnetic bead set PRCYTOMAG-40K (EMD Millipore). Samples were analyzed for Non-Human Primate (NHP)-specific TNFα, IFNγ, IL-6, IL-1β and IL-2 using the Luminex platform and performed as a multi-plex. Fluorescent color-coded beads coated with a specific capture antibody were added to each sample. After incubation and washing, biotinylated detection antibody was added followed by phycoerythrin-conjugated streptavidin. The beads were read on a Luminex instrument (Bioplex 200). Samples were run in duplicate and values were interpolated from five-parameter fitted standard curves.
+ Open protocol
+ Expand
6

Multiplex Cytokine Profiling in Serum

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum levels of cytokines including IFN-γ, IL-4, IL-17, IL-10, and TNF-α were determined using a magnetic bead-based multiplex assay kit (LXSAMSM-06, R&D Systems) following the manufacturer’s instructions. Data were collected on a Bio-Plex®200 (Luminex) and further analyzed using Bio-Plex Manager software v6.0.
+ Open protocol
+ Expand
7

Mapping CHIKV CP Epitopes with Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
A series of 20-mer peptides, with 10-residue overlaps, encompassing the entire CHIKV CP were designed (Table 2) and commercially synthesized (Mocell Biotech, Hong Kong). Each peptide was coupled to carboxylated polystyrene beads using the Bio-Plex amine coupling kit (Bio-Rad, Hercules, CA, USA) according to the manufacturer’s instructions. The coupled beads were then multiplexed by diluting in microsphere immunoassay (MIA) buffer (1% BSA, 0.05% ProClin 300 (Supelco, Bellefonte PA, USA) in PBS) and distributed to give approximately 2500 of each beadset (~100 µL) per well of a MultiScreen filter plate (Merck Millipore, Billerica, MA, USA). Each anti-CHIKV CP mAb was then tested against the multiplexed beadsets by incubation for 45 min with shaking at room temperature. The wells were then washed three times with PBS/T wash buffer, prior to the addition of R-Phycoerythrin donkey anti-mouse IgG (Jackson ImmunoResearch, West Grove, PA, USA). Following that, the wells were incubated and washed as previously, after which the beads were resuspended in MIA buffer. The Bio-Plex 200 (Luminex, Bio-Rad, Austin, TX, USA) was then utilized to read the plate, measuring the mean fluorescence intensity for each beadset in their respective wells. mAb recognition of peptides was also assessed by ELISA and dot blot as previously described [29 (link)].
+ Open protocol
+ Expand
8

Multiplex Assay for RSV Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
To quantify the concentration of RSV‐specific IgG and IgA, a multiplex immunoassay was performed as described before.31 Briefly, diluted plasma samples were incubated with RSV antigen‐coupled beads, including GA, GB, post‐F and pre‐F (DS‐CAV1 mutant).68 All antigens were produced in eukaryotic cells. Captured antibodies were detected with secondary R‐phycoerythrin‐labelled goat anti‐human IgA F(ab')2 (Southern Biotech, Birmingham) or IgG F(ab')2 (Jackson ImmunoResearch Laboratories, Ely). IgG was measured on a Bio‐Plex 200 (Luminex Corporation, Austin) in combination with Bio‐Plex Manager software version 6.1 (Bio‐Rad, Hercules). IgA was measured on a Flexmap 3D (Luminex Corporation) in combination with Xponent version 4.2 (Luminex Corporation). For each analyte, median fluorescence intensity (MFI) was converted to arbitrary units (AU) mL−1 by interpolation from a 5‐parameter logistic standard curve from an in‐house reference serum pool. Whereas all samples were tested in the NK cell activation assay, for some samples not enough volume remained to be tested in the IgG (n = 8) and/or IgA (n = 11) multiplex immunoassay. These samples were dispersed equally across the three different groups.
+ Open protocol
+ Expand
9

Cytokine Profile in Burned Skin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Burned skin (eschar) samples harvested by 7-mm biopsy punches (Acuderm, Fort Lauderdale, FL) were pulverized under liquid nitrogen using a Bessman Tissue Pulverizer (Spectrum, Inc., Rancho Dominguez, CA) and then homogenized in tissue lysis buffer according to the manufacture’s guide using a tissue tearer (IKA work, Inc., Wilmington, NC). After a freeze–thaw cycle and sonication, the samples were centrifuged and supernatants were collected. Total protein concentrations were determined with a Pierce™ BCA protein assay kit (Thermo Scientific, Rockford, IL). A Bio-Rad Rat 23-plex cytokine/chemokines panel (Bio-Rad Laboratories, Hercules, CA) was used to assay 23 different inflammatory mediators according to the manufacture’s guide. The standard curve for each of the cytokines and their quantification was measured using BioPlex 200 (Luminex 100/200, Austin, TX). The cytokine concentrations were calculated/normalized against its protein concentration of each tissue lysate.
+ Open protocol
+ Expand
10

HCMV Glycoprotein-Specific IgG Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A binding antibody multiplex assay (BAMA) was used to quantify HCMV glycoprotein–specific IgG binding and avidity (77 (link), 78 (link)). HCMV gB ectodomain, pentamer complex, gH/gL/gO, gH/gL, pp28, pp150, and UL44 antigens were covalently coupled to intrinsically fluorescent beads (Bio-Rad). Maternal and cord blood sera were diluted at 1:500 (for gB ectodomain, pentamer complex, gH/gL/gO, and gH/gL) and at 1:25 (for pp28, pp150, and UL44) in assay diluent, plated in duplicate, then coincubated with antigen-coupled beads. Antigen-specific IgG binding was detected with mouse anti-human IgG–PE (SouthernBiotech), and MFI was acquired on a Bio-Plex 200 (Luminex). For determination of avidity, duplicate wells were incubated with sodium citric acid (pH 4.0) or 1× PBS (pH 7.4) between the primary and secondary incubations, and RAI was calculated as (MFI with sodium citric acid)/(MFI with PBS) × 100%. A serial dilution of HCMV-hyperimmuneglobulin (Cytogam) was included as a positive control, and the cutoff for positivity was determined by calculating the mean MFI of seronegative serum binding plus 3 SDs. Blank beads and wells were included to account for background signal. Duplicates with CVs greater than 25% were repeated.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!